Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: Differential elevation of cyclooxygenase 2 in inflammatory joint diseases

Arthritis and Rheumatism

Volumn 41, Issue 1, 1998, Pages 122-129

  Siegle, Isabel ^a   Klein, Thomas ^b   Backman, Janne T ^a   Saal, Johannes G ^c   Nüsing, Rolf M ^b   Fritz, Peter ^d  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c St Franziskus Hospital   (Germany)

^d ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; PARAFFIN;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD VESSEL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

ADULT; AGED; ARTHRITIS; ARTHRITIS, PSORIATIC; AUTOANTIBODIES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS; PEROXIDASES; POLYMERASE CHAIN REACTION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; SPONDYLITIS, ANKYLOSING; SYNOVIAL MEMBRANE;

EID: 0031961901     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.0.CO;2-8     Document Type: Article

References (43)

1. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 1986;55:69-102.
2. DeWitt DL. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochem Biophys Acta 1991;1083:121-34.
3. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A 1991;88:2692-6.
4. O'Bunion MK, Sadowski HB, Winn V, Young DA. A serum-and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991;266:23261-7.
5. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-8.
6. Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989;259:315-24.
7. Otto JC, Smith WL. Prostaglandin endoperoxide synthases-1 and -2. J Lipid Mediat Cell Signal 1995;12:139-56.
8. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, Cirino G. Novel nonsteroidal anti-inflammatory drug derivates with markedly reduced ulcerogenic properties in the rat. Gastroenterology 1994;107:173-9.
9. Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract: the double-edged sword. Arthritis Rheum 1995;38:5-18.
10. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol Suppl 1996;102:9-21.
11. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992;89:4888-92.
12. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993;268:6610-4.
13. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994;91:12013-7.
14. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leaky KM, Smith WG, et al. Selective inhibition of inducible cyclooxygenase-2 in vivo is antitnflammatory and nonulcerogenic. Proc Natl Acad Sci U S A 1994;91:3228-32.
15. Robinson DR, Tashjian AHJ, Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia: a possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975;56:1181-8.
16. Dayer JM, Krane SM, Russell RGG, Robinson DR. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci U S A 1997;73:945-9.
17. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
18. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1β, phorbol ester, and corticosteroids. J Clin Invest 1994;93:1095-101.
19. Kang RY, Freire-Moar J, Sigal E, Chu CQ. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br J Rheumatol 1996;35:711-8.
20. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The Arthritis and Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Fritz P, Laschner W, Saal JG, Deichsel G, Ticzek HV, Wegner G. Histological classification of synovitis. Zentralbl Allg Pathol 1989;135:729-41.
23. Kömhoff M, Gröne HJ, Klein T, Seyberth H, Nüsing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for their renal functions. Am J Physiol 1997;272:F460-8.
24. Tam JP. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci U S A 1988;85:5409-13.
25. Klein T, Nüsing RM, Pfeilschifler J, Ullrich V. Selective inhibition of cyclooxygenase 2. Biochem Pharmacol 1994;48:1605-10.
26. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin complex in immunoperoxidase technics. Am J Clin Pathol 1981;75:816-21.
27. Fritz P, Tuczek HV, Öffinger B, Schwarzmann P, Schieszl S, Wu X, et al. Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients. J Histochem Cytochem 1992;26:146-58.
28. Schwarzmann P, Wu X, Fritz P, Tuczek HV. Histoanalyzer: a device for computer-assisted pathology. Ann Quant Cytol Histol 1994;16:71-2.
29. Maier JA, Hla T, Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 1990;265:10805-8.
30. Patrignani P, Panara MR, Greco A, Fusco O, Natoli C, Iacobelli S, et al. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 1994;271:1705-12.
31. Crofford LJ, Tan B, McCarthy CJ, Hla T. Involvement of nuclear factor κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 1997;40:226-36.
32. Ristimäki A, Garfinkel S, Wessendorf J, Maciag T, Hla T. Induction of cyclooxygenase-2 by interleukin-1alpha: evidence for post-transcriptional regulation. J Biol Chem 1994;269:11769-75.
33. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996;97:2672-9.
34. Salmon JA, Higgs GA, Vane JR, Bitensky C, Chayen J, Henderson B, et al. Synthesis of arachidonate cyclooxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture. Ann Rheum Dis 1983;42:36-9.
35. 2. Arthritis Rheum 1994;37:653-61.
36. Sano H, Hla T, Maier JAM, Crofford LJ, Case JP, Maciag T, et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 1992;89:97-108.
37. Szczepanski A, Moatter T, Carley WW, Gerritsen ME. Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1: inhibition by glucocorticoids. Arthritis Rheum 1994;37:495-503.
38. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
39. 2 by rheumatoid arthritis synovial cells in culture. Cytokine 1992;4:377-84.
40. 2 and cyclooxygenase-2. Eur J Biochem 1994;226:125-31.
41. Ueda N, Yamashita R, Yamamoto S, Ishimura K. Induction of cyclooxygenase-1 in human megakaryoblastic cell line (CMK) differentiated by phorbol ester. Biochem Biophys Acta 1997;1344:103-10.
42. Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, Rosenbaum JT. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia: results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum 1994;37:212-20.
43. Emery P. Clinical implications of selective cyclooxygenase-2 inhibition. Scand J Rheumatol 1996;25:23-8.